Back to search

Article

Long-term NAD+ supplementation prevents the progression of age-related hearing loss in mice

2022-08-26

Abstract excerpt

<h4>ABSTRACT</h4> Age-related hearing loss (ARHL) is the most common sensory disability associated with human aging. Yet, there are no approved measures for preventing or treating this debilitating condition. With its slow progression, continuous and safe approaches are critical for ARHL treatment. Nicotinamide Riboside (NR), a NAD+ precursor, is well tolerated even for long-term use and is already shown effectiv...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dc7d7b67-615c-54f5-a635-fe995ffbfcc9
DOI
10.1101/2022.08.25.505332
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Long-term NAD+ supplementation prevents the progression of age-related hearing loss in miceDOI 10.1101/2022.08.25.505332
Select a neighboring publication to make it the new centre.